E.S. Barr & Co’s CME Group CME Stock Holding History

E.S. Barr & Co’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.77M	Hold	6,000	–	–	0.1%	47
2025 Q4	$1.64M	Hold	6,000	–	–	0.09%	48
2025 Q3	$1.62M	Hold	6,000	–	–	0.09%	50
2025 Q2	$1.65M	Hold	6,000	–	–	0.09%	48
2025 Q1	$1.59M	Hold	6,000	–	–	0.1%	47
2024 Q4	$1.39M	Sell	6,000 -18	-0.3%	-$4.14K	0.08%	49
2024 Q3	$1.33M	Sell	6,018 -82	-1%	-$17K	0.08%	50
2024 Q2	$1.2M	Hold	6,100	–	–	0.08%	50
2024 Q1	$1.31M	Buy	6,100 +100	+2%	+$21K	0.09%	49
2023 Q4	$1.26M	Hold	6,000	–	–	0.09%	50
2023 Q3	$1.2M	Hold	6,000	–	–	0.09%	49
2023 Q2	$1.11M	Hold	6,000	–	–	0.08%	50
2023 Q1	$1.15M	Hold	6,000	–	–	0.1%	47
2022 Q4	$1.01M	Sell	6,000 -15	-0.2%	-$2.61K	0.08%	52
2022 Q3	$1.06M	Hold	6,015	–	–	0.09%	53
2022 Q2	$1.23M	Hold	6,015	–	–	0.1%	52
2022 Q1	$1.43M	Buy	+6,015	New	+$1.41M	0.1%	53

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

E.S. Barr & Co's CME Position: Q1 2026 in Review

E.S. Barr & Co held its CME Group (CME) position steady in Q1 2026 at 6,000 shares worth $1.77M. The position accounts for 0.1% of the portfolio, ranked #47.

E.S. Barr & Co first reported a position in CME in Q1 2022 and has held it in 17 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

E.S. Barr & Co held 6,000 shares of CME Group worth $1.77M as of Q1 2026.
E.S. Barr & Co left its CME Group share count unchanged in Q1 2026.
CME Group made up 0.1% of E.S. Barr & Co's portfolio in Q1 2026, its #47 holding.
E.S. Barr & Co first reported a position in CME Group in Q1 2022 and has held it in 17 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on E.S. Barr & Co's 13F filing for Q1 2026, filed 13 May 2026.